Acuta Capital Partners’s Vir Biotechnology VIR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-127,000	Closed	-$5.2M	–	53
2020 Q2	$5.2M	Buy	+127,000	New	+$5.2M	1.5%	27